Valuation: Abbott India Limited

Market Cap 592B 6.21B 5.4B 5.04B 4.62B 8.72B 8.87B 59.39B 23.26B 295B 23.32B 22.8B 973B P/E 2027 *
34.6x
P/E 2028 * 30.8x
Enterprise Value 568B 5.96B 5.18B 4.83B 4.44B 8.37B 8.51B 57B 22.32B 283B 22.38B 21.88B 934B EV / Sales 2027 *
7.56x
EV / Sales 2028 * 6.87x
Free-Float
24.45%
Yield 2027 *
2.08%
Yield 2028 * 2.23%
1 day-0.07%
1 week+0.12%
Current month+0.22%
1 month+7.72%
3 months+9.50%
6 months+3.63%
Current year-4.21%
1 week 27,450.45
Extreme 27450.45
28,080
1 month 25,950.35
Extreme 25950.35
29,250
Current year 25,164
Extreme 25164
29,250
1 year 25,164
Extreme 25164
34,035
3 years 21,907.45
Extreme 21907.45
35,921.55
5 years 15,525
Extreme 15525
35,921.55
10 years 3,996
Extreme 3996
35,921.55
Manager TitleAgeSince
Chief Executive Officer 46 2025-06-13
Director of Finance/CFO 52 2025-05-05
Director of Finance/CFO - 2025-03-31
Director TitleAgeSince
Chairman 83 1967-12-31
Director/Board Member 69 2011-02-28
Director/Board Member 71 2019-03-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.07%+0.12%-17.31%+13.43% 6.21B
+0.45%-7.89%+46.21%+150.14% 1T
-0.97%-5.58%+47.25%+48.99% 613B
-0.64%-7.40%+23.59%+64.97% 433B
+0.65%-2.61%+40.51%+35.18% 350B
+0.17%-4.31%+31.93%+40.09% 292B
+2.22%-9.27%+5.42%+7.61% 239B
+1.75%-8.29%-1.73%-42.05% 206B
+1.31%-2.45%+27.01%+57.63% 204B
-0.62%-2.75%+14.07%+66.01% 163B
Average +0.41%-3.47%+21.70%+44.20% 350.67B
Weighted average by Cap. +0.23%-4.33%+33.52%+70.75%

Financials

2027 *2028 *
Net sales 75.09B 788M 685M 639M 587M 1.11B 1.13B 7.54B 2.95B 37.44B 2.96B 2.89B 124B 82.25B 863M 750M 700M 643M 1.21B 1.23B 8.26B 3.23B 41.01B 3.24B 3.17B 135B
Net income 17.05B 179M 156M 145M 133M 251M 256M 1.71B 670M 8.5B 672M 657M 28.05B 19.12B 201M 174M 163M 149M 282M 287M 1.92B 752M 9.53B 753M 737M 31.45B
Net Debt -23.86B -250M -218M -203M -186M -352M -358M -2.39B -938M -11.9B -940M -919M -39.24B -26.92B -282M -245M -229M -210M -397M -404M -2.7B -1.06B -13.43B -1.06B -1.04B -44.28B
Logo Abbott India Limited
Abbott India Limited is an India-based pharmaceutical company. The Company is involved in product development, manufacturing, sales, and customer service. It distributes products and solutions in multiple therapeutic categories, such as women's health, gastroenterology, cardiology, metabolic disorders and primary care. It operates in a single reportable business segment, which is Pharmaceuticals. The Company’s products include Arachitol Nano, Digeraft, Influvac, Colospa, Duphalac, Librax, Creon, Duphaston, Prothiaden, Cremaffin, Duvadilan, Thyronorm, Cremaffin Plus, Ganaton, Udiliv, Digene, Heptral, Vertin, Zolfresh, Citrosoda UTI, Digene Insta On The Go, Digeraft tablet, Duphaston OD, Pneumoshield 14, Prothiaden Neu, Vonefi, Levesam, and LOBATE M Skin Cream, among others. The Company sells its products through independent distributors primarily within India.
Employees
3,679
Date Price Change Volume
26-08-04 27,845.85 -0.07% 168
26-08-03 ₹27,866.30 +0.30% 560
26-07-31 ₹27,784.15 +0.79% 413
26-07-30 ₹27,566.00 -0.56% 384
26-07-29 ₹27,720.05 -0.67% 812
Trader
Investor
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABBOTINDIA Stock